欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - cjepiva - profilaksa influence uzrokovana virusom a (h1n1) v 2009. celvapan mora se koristiti u skladu sa službenim vodstvom.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

pharmsure veterinary products europe ltd - soj mycoplasma synoviae ms-h - imunomodulatori za ptice, živih bakterijskih cjepiva - piletina - za aktivne imunizacije budućnost roditeljskog jata tovnih pilića, budućnost sloj uzgajivač kokoši i pilića budućnost sloj za smanjenje sac zraka osipa i smanjiti broj jaja s anomalija jajeta obrazovanja, uzrokovane mycoplasma synoviae.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis serotip b fhbp (rekombinantni lipidirani fhbp (protein koji veže faktor h)) podfamilija a; neisseria meningitidis serotip b fhbp (rekombinantni lipidirani fhbp (faktor vezanja h proteina)) podskupina b - meningitis, meningokokal - bacterial vaccines, meningococcal vaccines - trumenba je indicirana za aktivnu imunizaciju osoba starijih od 10 godina kako bi se spriječila invazivna meningokokna bolest uzrokovana neisseria meningitidis serotipom b. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

bavarian nordic a/s, philip heymans allé 3, hellerup, danska - virus bjesnoće, soj flury lep (inaktiviran) - prašak i otapalo za otopinu za injekciju u napunjenoj štrcaljki - 1 doza = 1 ml - urbroj: 1 bočica (1,0 ml) nakon rekonstitucije sadrži: virus bjesnoće (inaktivirani, soj flury lep) ≥ 2,5 internacionalne jedinice (iu), proizveden na pročišćenim stanicama pilećih embrija (pcec)

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

elanco gmbh - Žive ne patogene escherichia coli o141: k94 (f18ac) i o8: k87 (f4ac) - immunologicals for suidae, live bacterial vaccines - svinje - za aktivnu imunizaciju svinja od 18 dana starosti protiv enterotoksičnog f4-pozitivnih i f18-pozitivnih escherichia coli, kako bi se smanjila učestalost umjerene do teške poslije odbića e. (pwd) u zaraženim svinjama i da se smanji fekalna prolijevanja enterotoksičnog f4-pozitivnih i f-18-pozitivnih e. coli iz zaraženih svinja.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

ceva santé animale - inaktiviran coxiella burnetii cjepivo, soj nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - smanjenje neonatalne enterotoksikoze prasadi uzrokovano e. coli, koji eksprimiraju adhezinje f4ab, f4ac, f4ad, f5, f6 i f41 tijekom prvih dana života.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

intervet international b.v. - svinjski circovirus tip 2 orf2 podjedinica antigena - immunologicals for suidae, inactivated viral vaccines - svinje - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection.  to reduce loss of daily weight gain and mortality associated with pcv2 infection.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - tetani клостридия virus анатоксин / pds 2242 virus / virus vcp1529 / vcp1533 virus / vcp3011 - immunologicals for equidae, live viral and inactivated bacterial vaccines, equine influenza virus + clostridium - konji - aktivna imunizacija konja od četiri mjeseca ili starije od konjske gripe radi smanjenja kliničkih znakova i izlučivanja virusa nakon infekcije i protiv tetanusa radi sprječavanja smrtnosti.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - svinje - za aktivnu imunizaciju svinja od sedam tjedana pa nadalje kako bi se spriječila smrtnost i smanjila infekcija i bolesti uzrokovane virusom klasične svinjske kuge (csfv). onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv. onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.